Steven Evans is the Chief Scientific Officer and Senior Vice President of Research and Development at NTx, where they focus on innovative advancements in cell-free biomanufacturing. With over 20 years of experience in drug discovery and development at leading pharmaceutical companies like Pfizer and GSK, they have successfully managed complex R&D projects and led multinational teams. Steven's expertise extends across multiple disease areas, emphasizing inflammation and immunology, and includes extensive work in translational strategies and strategic business development initiatives. They hold a Ph.D. in Physiology from King's College London, where they also completed their B.Sc. in Pharmacology with Toxicology.
This person is not in any teams
This person is not in any offices